Efficacy of current growth hormone treatments and future therapies

Despite huge advances having been made in some areas of medicine, options for the treatment of GH deficiency (GHD) have remained constant since the introduction of GH in the 1950s. Several initiatives have been introduced to improve the understanding and treatment of GHD with GH, including the long-term Hypopituitary Control and Complications Study (HypoCCS) and the issuance of clinical guidelines. This article considers the impact of these initiatives and considers new treatment options which will potentially provide important future benefits for GHD patients.